Clinical Trial Update: LYT-100 in Patients With Idiopathic Pulmonary Fibrosis (IPF) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of LYT-100 for idiopathic pulmonary fibrosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• LYT-100

Snippet

Sponsor: PureTech | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING